Community-acquired pneumonia: Similarities and differences between european and american guidelines-a narrative review

José Barberán, Rubén Restrepo, Pablo Cardinal-Fernández

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Community-acquired pneumonia (CAP) is severe disease. Early prescription of an adequate treatment has a positive impact in the CAP outcome. Despite the evidence of existing relevant differences between CAP across geographical areas, general guidelines can be designed to be applied everywhere. Eight years have passed between the publication of the European (EG) and American (AG) CAP guidelines, thus the aim of this narrative review is to compare both guidelines and sum-marize their recommendations. The main similarity between both guidelines is the antibiotics recommendation with the exception that AG mention new antimicrobials that were not available at the time of EG publication. Both guidelines recommend against routinely adding steroids as an adjuvant treat-ment. Finally, both guidelines acknowledge that the decision to hospitalize a patient is clinical and should be complemented with an objective tool for risk assessment. EG recommend the CRB-65 while AG recommend the Pneumonia Severity Index (PSI). EG and AG share a similar core of recommendations and only differ in minor issues such as new antibiotics. Likewise, both guidelines recommend against the routine prescription of steroids as an adjuvant therapy.

Original languageEnglish (US)
Pages (from-to)72-80
Number of pages9
JournalRevista Espanola de Quimioterapia
Issue number2
StatePublished - 2021


  • American guidelines
  • Community-Acquired Pneumonia
  • European guidelines
  • Respiratory infections

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology


Dive into the research topics of 'Community-acquired pneumonia: Similarities and differences between european and american guidelines-a narrative review'. Together they form a unique fingerprint.

Cite this